DNA Hypermethylation in the Normal Colonic Mucosa of Patients with Colorectal Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 2006 Jan 20

PMID 16421593

Citations 52

Authors

K Kawakami

A Ruszkiewicz

G Bennett

J Moore

F Grieu

G Watanabe

B Iacopetta

Affiliations

Soon will be listed here.

Abstract

The CpG-island methylator phenotype (CIMP+) in colorectal cancer (CRC) is characterised by frequent hypermethylation of promoter regions in tumour suppressor genes. Low level methylation of some CpG islands is also seen in the normal colonic mucosa and increases with age; however, it is still unclear what other factors regulate this phenomenon. The first aim of our study was to determine whether the level of promoter methylation is elevated in the normal colonic mucosa of patients with CIMP+ tumours. The second aim was to investigate whether common, functional polymorphisms in genes involved in methyl group metabolism are associated with the level of methylation in this tissue. CpG islands within the ERalpha, MYOD, P16(INK4A), MLH1, APC, P14(ARF), DAPK and TIMP3 genes were quantitatively evaluated for methylation in normal colonic mucosa from a large series of CRC patients using the MethyLight assay. Genotyping was carried out for polymorphisms in the MTHFR, TS, MS, MTHFD1 and DNMT3b genes. Methylation of ERalpha and MYOD in normal colonic mucosa increased with age and was higher in female subjects. Methylation of P16(INK4A), MLH1, TIMP3 and DAPK in normal mucosa occurred at a lower level than ERalpha and MYOD but also increased with age and was significantly higher in patients with CIMP+ tumours. The DNMT3b C46359T polymorphism was associated with significantly less methylation of MYOD and MLH1 and with trends for lower methylation in each of the other CpG islands examined. Our results demonstrate that age, gender and genetic factors can influence the methylation level of CpG islands in gene promoter regions of normal colonic mucosa. Further work is required to determine whether such methylation is associated with the development of CIMP+ CRC.

Citing Articles

The Role of DNA Methylation in Gastrointestinal Disease: An Expanded Review of Malignant and Nonmalignant Gastrointestinal Diseases.

Kalra A, Meltzer S Gastroenterology. 2024; 168(2):245-266.

PMID: 38971197 PMC: 11698954. DOI: 10.1053/j.gastro.2024.07.001.

DNA-methylation variability in normal mucosa: a field cancerization marker in patients with adenomatous polyps.

Yates J, Schaufelberger H, Steinacher R, Schar P, Truninger K, Boeva V J Natl Cancer Inst. 2024; 116(6):974-982.

PMID: 38273663 PMC: 11160500. DOI: 10.1093/jnci/djae016.

The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study.

Roberto M, Arrivi G, Pilozzi E, Montori A, Balducci G, Mercantini P Cancer Manag Res. 2022; 14:1353-1369.

PMID: 35418781 PMC: 9000544. DOI: 10.2147/CMAR.S342612.

MutL homolog 1 methylation and microsatellite instability in sporadic colorectal tumors among Filipinos.

Cabral L, Mapua C, Natividad F, Sukowati C, Cortez E, Enriquez M World J Gastrointest Oncol. 2022; 13(12):2101-2113.

PMID: 35070045 PMC: 8713326. DOI: 10.4251/wjgo.v13.i12.2101.

Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer.

Grady W, Yu M, Markowitz S Gastroenterology. 2020; 160(3):690-709.

PMID: 33279516 PMC: 7878343. DOI: 10.1053/j.gastro.2020.09.058.

References

Issa J . Aging, DNA methylation and cancer. Crit Rev Oncol Hematol. 1999; 32(1):31-43. DOI: 10.1016/s1040-8428(99)00019-0. View

Issa J, Ottaviano Y, Celano P, Hamilton S, Davidson N, Baylin S . Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994; 7(4):536-40. DOI: 10.1038/ng0894-536. View

Eads C, Lord R, Wickramasinghe K, Long T, Kurumboor S, Bernstein L . Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res. 2001; 61(8):3410-8. View

Nakagawa H, Nuovo G, Zervos E, Martin Jr E, Salovaara R, Aaltonen L . Age-related hypermethylation of the 5' region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res. 2001; 61(19):6991-5. View

Friso S, Choi S, Girelli D, Mason J, Dolnikowski G, Bagley P . A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci U S A. 2002; 99(8):5606-11. PMC: 122817. DOI: 10.1073/pnas.062066299. View

Hawkins N, Norrie M, Cheong K, Mokany E, Ku S, Meagher A . CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002; 122(5):1376-87. DOI: 10.1053/gast.2002.32997. View

Paz M, Avila S, Fraga M, Pollan M, Capella G, Peinado M . Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 2002; 62(15):4519-24. View

Waki T, Tamura G, Tsuchiya T, Sato K, Nishizuka S, Motoyama T . Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol. 2002; 161(2):399-403. PMC: 1850716. DOI: 10.1016/S0002-9440(10)64195-8. View

Choi S, Mason J . Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002; 132(8 Suppl):2413S-2418S. DOI: 10.1093/jn/132.8.2413S. View

10.

Shen H, Wang L, Spitz M, Hong W, Mao L, Wei Q . A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. Cancer Res. 2002; 62(17):4992-5. View

11.

Whitehall V, Wynter C, Walsh M, Simms L, Purdie D, Pandeya N . Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res. 2002; 62(21):6011-4. View

12.

van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B . Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002; 51(6):797-802. PMC: 1773491. DOI: 10.1136/gut.51.6.797. View

13.

Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L . Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology. 2003; 34(6):541-7. DOI: 10.1080/0031302021000035965-2. View

14.

Bariol C, Suter C, Cheong K, Ku S, Meagher A, Hawkins N . The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol. 2003; 162(4):1361-71. PMC: 1851239. DOI: 10.1016/S0002-9440(10)63932-6. View

15.

Merlo A, Herman J, Mao L, Lee D, Gabrielson E, Burger P . 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995; 1(7):686-92. DOI: 10.1038/nm0795-686. View

16.

Kane M, Loda M, Gaida G, Lipman J, Mishra R, Goldman H . Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997; 57(5):808-11. View

17.

Baylin S, Herman J, Graff J, Vertino P, Issa J . Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res. 1997; 72:141-96. View

18.

Ahuja N, Li Q, Mohan A, Baylin S, Issa J . Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998; 58(23):5489-94. View

19.

Toyota M, Ahuja N, Herman J, Baylin S, Issa J . CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999; 96(15):8681-6. PMC: 17576. DOI: 10.1073/pnas.96.15.8681. View

20.

Rashid A, Issa J . CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology. 2004; 127(5):1578-88. DOI: 10.1053/j.gastro.2004.09.007. View